The Research and Development team at Overland Pharmaceuticals is responsible for pioneering and advancing innovative oncology therapies, including first-in-class ADC and allogeneic cell therapy programs, tailored for the greater China and Asia markets. Comprised of scientists, senior scientists, lab managers, and directors specializing in cell therapy and engineering, this team leverages both strategic global partnerships and internal technology platforms to develop and commercialize leading-edge medical treatments.
View all